{"name":"TaiMed Biologics Inc.","slug":"taimed-biologics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2018-01-01","label":"Trogarzo first approved","drug":"Trogarzo","drugSlug":"ibalizumab","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Trogarzo","genericName":"IBALIZUMAB","slug":"ibalizumab","indication":"Human immunodeficiency virus infection","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"ibalizumab-uiyk","genericName":"ibalizumab-uiyk","slug":"ibalizumab-uiyk","indication":"Treatment-experienced HIV-1 infection","status":"phase_3"}]}],"pipeline":[{"name":"Trogarzo","genericName":"IBALIZUMAB","slug":"ibalizumab","phase":"marketed","mechanism":"Trogarzo works by binding to the CD4 receptor on T-cells, preventing HIV from entering and infecting these cells.","indications":["Human immunodeficiency virus infection"],"catalyst":""},{"name":"ibalizumab-uiyk","genericName":"ibalizumab-uiyk","slug":"ibalizumab-uiyk","phase":"phase_3","mechanism":"Ibalizumab-uiyk is a monoclonal antibody that binds to the CD4 receptor on T cells, preventing HIV entry and replication.","indications":["Treatment-experienced HIV-1 infection"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQZk9MN1pUd2s0bzR3MVNUdUh1ZmhZbHFkTGwzVjBGRHJ4MHcxaERlTG1WNGt3OGNKZ2NkMldGSUhGdTl2OURqNmlhWVZ0b1pyNnJtOUhwVUhtZEY2ZTZ5MXJmWlBTM00tbkZvQTNwTk04LThNX0lNRjAxUEp6U1RuNm5qeTlha1lQbjZYRTBlZlpTRlNtRk5ycHhFck1FMEloUE5WYTBZUW9Xa3c4QzM1TXd3?oc=5","date":"2025-12-09","type":"pipeline","source":"businessfocusmagazine.com","summary":"TaiMed Biologics - businessfocusmagazine.com","headline":"TaiMed Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxQYTVPVU5zRmprdEVIZHdCM1JSTTNINmhIUmR6a2NOZ3dFS3RBUkx2N19kY0xaNXVxdlM2RGZfdmFxVmg1VVY5eGNaMnBCanZ1bUxVbjdpMkt2dW5NT0ZxN1JjNlQwYjE2bnZ4OEFpNXREVXNjaHVSNmpoQnVFOEhkS0NnRkhlNFpJOFQzSjVmLXNabDdjTXNPX1VKTjhMVzR3VVpXSUdTdUEwXzFjUmFiZ2o3MEs1bmRoVVRyNkd6RmdYQXVXaTJLdXpFY3Vvb2xPQ3NqcThMS2FiWHlLdDNfd09pOTdRbmRWSTROcmJpbHg?oc=5","date":"2025-03-17","type":"trial","source":"BioSpace","summary":"TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025 - BioSpace","headline":"TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPZWlqODhhUHltc2xQOGpSRFJScWtJRUgtR3ZMSnZqdkxLRUtCY3NwOEdnNnkwYnlBaVZ5czJsN1A0VzNqT3pkTFNuekFIZ0FkRE95RVpvaFIwYmdLWm4xd2o0VVpqT1JkV0toZ2tqWm93Y0hyWDRWZUxfRXYyaWlfUUFpUDkwV1IwRWs5c2RENG16M0N3UDhxbjNqV0RMZEpBY2xRZTBXLWJBY0R2WVVZVElGRS1SZmtlNXluWTU5RQ?oc=5","date":"2023-03-27","type":"deal","source":"eatg.org","summary":"WEP Clinical has partnered with TaiMed Biologics to launch a Trogarzo named patient program - eatg.org","headline":"WEP Clinical has partnered with TaiMed Biologics to launch a Trogarzo named patient program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE4xdGhrVnVjSjRqbmhSTklmLVFYNzZIVEFBb3VZQW1VMFpETVZNNWh1NGZndERaMHFfZWlLTEs4N082akV5ZUFmWWhNSjV2dFQ4OVBVeW0zUDZLak9GV3h6SDI0NmVZNHpFcU80RFBxUTV4NkpYbWhNRlBZMkR3cWs?oc=5","date":"2018-08-01","type":"pipeline","source":"DCAT Value Chain Insights","summary":"Emerging Pharma: Who is Rising to the Top? - DCAT Value Chain Insights","headline":"Emerging Pharma: Who is Rising to the Top?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQem1FWmZyQXB0NEtNcG83bmp6ektkOTNNbUtua2puVE5iUTJmTHI3bXNERUUwMFgtM0lRS0lNTExnbTZsTW5xME1GVW1yakVrSzIyZEpGT1E3d1FRazRGNEdwVFdzblc0a2RGRE1JLS1kUjNhSEF0UXZNZmFid3Zra1BEX0RrVklPeGxwN2pGN01KaVFJZVUxdEJjY1hHbE83UzlBR24yUDdtRjg?oc=5","date":"2018-04-30","type":"pipeline","source":"Fierce Pharma","summary":"China's WuXi Biologics to build biologics plant in Ireland that will employ 400 - Fierce Pharma","headline":"China's WuXi Biologics to build biologics plant in Ireland that will employ 400","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQNG52UmN5TWhMeklJSlJEYXliTTdGeDBPWGYyUmlEM2dQSm90dnhxWTVqTXlKTUJ1Nm5oTmNsRGF1WXJveGZvQWs4T0dBckY4ckpYUWhJc1VUOFBicnJwN0c1V2xueVRvTHlESHYtdlREYkhwUmNlN1FOSklxdlBZdzVVZzBEdm93eDd4aEJOQkpvY0trX3V6T0RYWExscVpZNXJ3cVkyVTI3THZZNmtXV3VjZ20xb1M0WWdxMDNOWQ?oc=5","date":"2018-03-08","type":"regulatory","source":"Fierce Pharma","summary":"WuXi Biologics is producing a newly approved HIV med in the first Chinese biologics plant approved by the FDA - Fierce Pharma","headline":"WuXi Biologics is producing a newly approved HIV med in the first Chinese biologics plant approved by the FDA","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNSGVseWV0c1pnWUw2WkhmSDNNbWdvaUdpVXZNek03TzNyQmpQMGxyRUJUajRrZXhmdDZvTUhaLUczcUF0ZmxRYVBPSFdmX2d2c2xieGdVZ0Q4dmtJNEkyX04yZkwwOVV6LVhPbW9QV3o5SEVDdFVWdjFCTUJGSFpuQVM3UWFRTFNIc3hpSDBiQ052R2J3WnJnS09vcw?oc=5","date":"2018-03-07","type":"regulatory","source":"Fierce Pharma","summary":"Taiwanese company wins FDA approval for HIV treatment with new mechanism of action - Fierce Pharma","headline":"Taiwanese company wins FDA approval for HIV treatment with new mechanism of action","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBUNHY2LVR4Sm9DR1NCRjRTV2xfR3VFTU9kQVNzZkE2TlFoLURMV2NnUUp0NFlOZk5kakI1RThTeUN5Wm9yXzJKdmxpODlpTk9MX2lHaHoxS2Q0WEtvaC1v?oc=5","date":"2018-01-15","type":"pipeline","source":"Yahoo Finance Singapore","summary":"TaiMed Biologics Inc. (4147.TWO) interactive stock chart - Yahoo Finance Singapore","headline":"TaiMed Biologics Inc. (4147.TWO) interactive stock chart","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQNW00RXozSy1STWxMNzlUQV9vVWdoWDZoblpPOF9ETE1RMmxWUUNKaklpdnNkbFhKT0NobVhmeFZRU05sUy03WHI0LW9mN0xDMmJEdDI3alhKZVIxMjJsNDFvbEJfS1lPZVBIcC10d095dm1Kd1VvZWRhQjFITGhVZF9vSVVDckVHVUY0R01LMDZ3TkVER3Nmam9LZUM3aVBnOWYzQmpKVHRIblFnTFlnOUdPcmFvN2h1ZU9nTks1RDFrZkh4Zm04?oc=5","date":"2017-12-06","type":"pipeline","source":"Fierce Pharma","summary":"WuXi says it has China's largest biologics manufacturing plant up and running - Fierce Pharma","headline":"WuXi says it has China's largest biologics manufacturing plant up and running","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}